Pheniramine MaleateCAS# 132-20-7 |
- Metformin HCl
Catalog No.:BCC4799
CAS No.:1115-70-4
- Lenalidomide (CC-5013)
Catalog No.:BCC2245
CAS No.:191732-72-6
- Gliclazide
Catalog No.:BCC5002
CAS No.:21187-98-4
- Geniposide
Catalog No.:BCN5104
CAS No.:24512-63-8
- MEK inhibitor
Catalog No.:BCC1738
CAS No.:334951-92-7
- Imeglimin hydrochloride
Catalog No.:BCC4085
CAS No.:775351-61-6
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 132-20-7 | SDF | Download SDF |
| PubChem ID | 5282139 | Appearance | Powder |
| Formula | C20H24N2O4 | M.Wt | 356.42 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | H2O : ≥ 38 mg/mL (106.62 mM) *"≥" means soluble, but saturation unknown. | ||
| Chemical Name | (Z)-but-2-enedioic acid;N,N-dimethyl-3-phenyl-3-pyridin-2-ylpropan-1-amine | ||
| SMILES | CN(C)CCC(C1=CC=CC=C1)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O | ||
| Standard InChIKey | SSOXZAQUVINQSA-BTJKTKAUSA-N | ||
| Standard InChI | InChI=1S/C16H20N2.C4H4O4/c1-18(2)13-11-15(14-8-4-3-5-9-14)16-10-6-7-12-17-16;5-3(6)1-2-4(7)8/h3-10,12,15H,11,13H2,1-2H3;1-2H,(H,5,6)(H,7,8)/b;2-1- | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Pheniramine Maleate Dilution Calculator
Pheniramine Maleate Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.8057 mL | 14.0284 mL | 28.0568 mL | 56.1136 mL | 70.142 mL |
| 5 mM | 0.5611 mL | 2.8057 mL | 5.6114 mL | 11.2227 mL | 14.0284 mL |
| 10 mM | 0.2806 mL | 1.4028 mL | 2.8057 mL | 5.6114 mL | 7.0142 mL |
| 50 mM | 0.0561 mL | 0.2806 mL | 0.5611 mL | 1.1223 mL | 1.4028 mL |
| 100 mM | 0.0281 mL | 0.1403 mL | 0.2806 mL | 0.5611 mL | 0.7014 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Pheniramine Maleate is an antihistamine with anticholinergic properties used to treat allergic conditions such as hay fever or urticaria.
- Diphenylpyraline HCl
Catalog No.:BCC3768
CAS No.:132-18-3
- Benztropine mesylate
Catalog No.:BCC4524
CAS No.:132-17-2
- Shizukaol A
Catalog No.:BCN6984
CAS No.:131984-98-0
- 3,6,19-Trihydroxy-23-oxo-12-ursen-28-oic acid
Catalog No.:BCN1584
CAS No.:131984-82-2
- CC0651
Catalog No.:BCC4200
CAS No.:1319207-44-7
- 1,3,6,8-tetrahydroxy-4-(3-methyl-2-buten-1-yl)-9H-Xanthen-9-one
Catalog No.:BCN1585
CAS No.:1319198-98-5
- Paricalcitol
Catalog No.:BCC1839
CAS No.:131918-61-1
- Solanesol
Catalog No.:BCN2596
CAS No.:13190-97-1
- Goitrin
Catalog No.:BCN2764
CAS No.:13190-34-6
- Fudosteine
Catalog No.:BCC4661
CAS No.:13189-98-5
- 2-Hydroxyethyl Salicylate
Catalog No.:BCN3579
CAS No.:87-28-5
- (3R)-(+)-1-Benzyl-3-(tert-butoxycarbonylamino)pyrrolidine
Catalog No.:BCC8389
CAS No.:131878-23-4
- Benzydamine HCl
Catalog No.:BCC4637
CAS No.:132-69-4
- Dihydrocucurbitacin B
Catalog No.:BCN3118
CAS No.:13201-14-4
- UNC 0646
Catalog No.:BCC2431
CAS No.:1320288-17-2
- UNC 0631
Catalog No.:BCC4143
CAS No.:1320288-19-4
- Cryptoacetalide
Catalog No.:BCN3139
CAS No.:132059-23-5
- Marmesin angelate
Catalog No.:BCN8139
CAS No.:13209-79-5
- Ropivacaine hydrochloride monohydrate
Catalog No.:BCC5169
CAS No.:132112-35-7
- O,O-diacetyldaurisoline
Catalog No.:BCC8221
CAS No.:132139-17-4
- Epi-Cryptoacetalide
Catalog No.:BCN3140
CAS No.:132152-57-9
- Dracoflavan A
Catalog No.:BCN3588
CAS No.:132185-42-3
- 5alpha-Hydroxycostic acid
Catalog No.:BCN6169
CAS No.:132185-83-2
- 5beta-Hydroxycostic acid
Catalog No.:BCN6170
CAS No.:132185-84-3
Effect of Dexamethasone and Pheniramine Maleate in Patients Undergoing Elective Laparoscopic Cholecystectomy.[Pubmed:26982667]
JNMA J Nepal Med Assoc. 2014 Jul-Sep;52(195):920-4.
INTRODUCTION: Laparoscopic cholecystectomy (LC) is elective surgical procedure for uncomplicated gallstone disease and gallbladder polyp. The objective of this study was to assess the efficacy of Dexamethasone and Pheniramine hydrogen maleate on reducing stress response and pain after surgery in patients undergoing laparoscopic cholecystectomy. METHODS: After obtaining approval from the institutional ethics committee and written informed consent, 120 patients undergoing elective laparoscopic cholecystectomy were enrolled in the study from Sep 2103 to Aug 2014 at Department of Surgery, Manipal College of Medical Sciences, Pokhara, Nepal. Patients were randomized to receive either 8mg/2ml of Dexamethasone + 45.5/2ml Pheniramine hydrogen maleate (treatment group, n= 60) or 5 ml of normal saline (control group, n=60) 90 minutes before skin incision. RESULTS: There was a reduction of total bilirubin, C-reactive protein (CRP) value and Visual Analogue Score (VAS) in treatment group as compared to control group (p <0.05). CONCLUSIONS: Use of Dexamethasone and Pheniramine hydrogen maleate prior to surgical skin incision helps to reduce both postoperative pain and acute physiological stress.
EFFECTS OF DEXAMETHASONE AND PHENIRAMINE MALEATE ON HEMODYNAMIC AND RESPIRATORY PARAMETERS AFTER CEMENTATION IN CEMENTED PARTIAL HIP PROSTHESIS.[Pubmed:26121896]
Middle East J Anaesthesiol. 2015 Feb;23(1):55-62.
PURPOSE: To prevent hemodynamic and respiratory changes that are likely to occur during cementation in partial hip prosthesis by prophylactic use of Pheniramine Maleate and dexamethasone. METHODS AND MATERIALS: The study included 40 patients aged between 60 and 85 years with an American Society ofAnesthesiologists (ASA) grade of II-III who underwent partial hip prosthesis. Just after spinal anesthesia, 4 mL normal saline was pushed in patients in Group S, whereas 45.5 mg Pheniramine Maleate and 8 mg dexamethasone mixture was pushed intravenously in a total volume of 4 mL in patients in Group PD. RESULTS: Amounts of atropine and adrenaline administered after cementation were significantly higher in Group S than in Group PD (P < 0.05). There was a significant difference between SpO2 values before and after cementation in Group S; SpO2 value was lower after cementation (P < 0.05) except for 1. min after cementation. SpO2 value increased 1 min after cementation (P = 0.031) CONCLUSION: Prophylactic use of Pheniramine Maleate and dexamethasone in partial hip prosthesis led to an increase in SpO2 value and a decrease in the utilization of adrenaline and atropine after cementation.
Pheniramine Maleate is more effective than Lidocaine on Fentanyl Induced Cough.[Pubmed:27375720]
Pak J Med Sci. 2016 May-Jun;32(3):715-9.
OBJECTIVE: Fentanyl is frequently used during anesthesia induction. The use of fentanyl can cause cough through different mechanisms. Here, we aimed to investigate effects of Pheniramine Maleate (PM), an antihistaminic agent, and compare it with lidocaine on fentanyl induced cough. METHODS: This is a randomized double-blind prospective clinical study of ASA I-II, 120 patients scheduled for elective abdominal surgery. Patients were administered drugs intravenously and randomly allocated into three groups: Group C (2 ml 0.9 % normal saline), Group L (1mg/kg lidocaine), and Group F (PM 45.5 mg). 90 seconds after administration, 2micro/kg fentanyl was applied in three seconds to all patients. Severity of cough (mild: 1-2, moderate: 3-5, severe> 5), time of the cough and vital parameters were recorded 90 seconds after fentanyl injection. RESULTS: Eight patients (25%) in Group C had fentanyl induced cough whereas three patients (7.5%) in Group L and one patient (2.5%) in Group F experienced this phenomenon. There was statistically significant difference between Group F and Group C (p<0.05); however, differences between Group L and Group C or Group F and Group L were not statistically significant (p>0.05). CONCLUSIONS: Pheniramine Maleate 45.5 mg is better that placebo and as effective as lidocaine to prevent fentanyl induced cough.
Pheniramine Maleate-Induced Rhabdomyolysis and Aki: Is it Fatal?[Pubmed:25948974]
Toxicol Int. 2014 Sep-Dec;21(3):319-21.
Pheniramine Maleate is an easily accessible, over-the-counterantihistaminic, which is frequently involved in overdoses. Pheniramine has antimuscarinic effect causing tachycardia, dilated pupils, urinary retention, and dry flushed skin, and decreased bowel sounds, confusion, mild increase in body temperature, cardiac arrhythmias, and seizures at lethal doses. It has not been implicated as an important cause of rhabdomyolysis and acute kidney injury (AKI). Rhabdomyolysis causing AKI is rarely reported in the literature. This case report emphasizes the occurrence of nontraumatic rhabdomyolysis in Pheniramine Maleate overdose which required hemodialysis. Since there is a lack of a specific antidote, treatment is mainly symptomatic and supportive. We report a fatal case of a young male with a very high dose of consumption of Pheniramine Maleate (4.077 g), which was complicated by seizures, respiratory depression, nontraumatic rhabdomyolysis, and AKI. Despite hemodialysis, ventilator support, and other intensive supportive care, patient could not survive and death ensued due to multiorgan dysfunction syndrome.
